Literature DB >> 35130919

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.

Chris Ebong1, Asadu Sserwanga2, Jane Frances Namuganga2, James Kapisi2, Arthur Mpimbaza2, Samuel Gonahasa2, Victor Asua2, Sam Gudoi3, Ruth Kigozi3, James Tibenderana3, John Bosco Bwanika3, Agaba Bosco4, Denis Rubahika4, Daniel Kyabayinze4, Jimmy Opigo4, Damian Rutazana4, Gloria Sebikaari5, Kassahun Belay5, Mame Niang5, Eric S Halsey6, Leah F Moriarty6, Naomi W Lucchi6, Samaly S Svigel Souza6, Sam L Nsobya2,7, Moses R Kamya2,7, Adoke Yeka2,7.   

Abstract

Entities:  

Year:  2022        PMID: 35130919      PMCID: PMC8822855          DOI: 10.1186/s12936-022-04049-1

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


× No keyword cloud information.

Correction to: Malaria Journal (2021) 20:484 https://doi.org/10.1186/s12936-021-04021-5

Following publication of the original article [1], it was brought to the publisher’s attention that incorrect details had been provided in the trial registration information of the article. Where it should read: Trial registration: The trial was also registered with the Pan African Clinical Trial Registry (https://pactr.samrc.ac.za/) with study Trial No. PACTR201811640750761. It said: Trial registration: The trial was also registered with the ISRCTN registry with study Trial No. PACTR201811640750761. The original article has been updated accordingly.
  1 in total

1.  Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.

Authors:  Chris Ebong; Asadu Sserwanga; Jane Frances Namuganga; James Kapisi; Arthur Mpimbaza; Samuel Gonahasa; Victor Asua; Sam Gudoi; Ruth Kigozi; James Tibenderana; John Bosco Bwanika; Agaba Bosco; Denis Rubahika; Daniel Kyabayinze; Jimmy Opigo; Damian Rutazana; Gloria Sebikaari; Kassahun Belay; Mame Niang; Eric S Halsey; Leah F Moriarty; Naomi W Lucchi; Samaly S Svigel Souza; Sam L Nsobya; Moses R Kamya; Adoke Yeka
Journal:  Malar J       Date:  2021-12-24       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.